Galapagos NV
GLPG
#5032
Rank
C$2.65 B
Marketcap
C$39.47
Share price
0.00%
Change (1 day)
4.07%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): C-$0.76

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.58. In 2025 the company made an earnings per share (EPS) of C$8.14 an increase over its 2024 EPS that were of C$1.66.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.76-109.33%
2025C$8.14390.86%
2024C$1.66-67.16%
2023C$5.05-199.64%
2022C-$5.0799.03%
2021C-$2.55-68.98%
2020C-$8.21-298.06%
2019C$4.15-554.64%
2018C-$0.91-77.18%
2017C-$4.00-326.21%
2016C$1.77-134.19%
2015C-$5.17-371.34%
2014C$1.90-445.98%
2013C-$0.5532.88%
2012C-$0.41-82.07%
2011C-$2.31-817.9%
2010C$0.3212.73%
2009C$0.29-120.79%
2008C-$1.37-37.67%
2007C-$2.2039.64%
2006C-$1.5828.17%
2005C-$1.236.25%
2004C-$1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.44-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.14-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.93-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.64-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$5.06-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.89-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$5.53-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C-$0.87 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.95-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel